Trademark: 98141705
Word
BIVISION
Status Date
Tuesday, May 28, 2024
Filing Date
Sunday, August 20, 2023
Published for Opposition
Tuesday, May 28, 2024
5 Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medicinal use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in urology; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents
The mark consists of the stylized wording of "Bivision". The mark further consists of a stylized atom as the letter "O" in "Bivision".
Color is not claimed as a feature of the mark.
Aug 25, 2023
New Application Entered
Sep 19, 2023
New Application Office Supplied Data Entered
Sep 20, 2023
Notice Of Design Search Code E-Mailed
Apr 18, 2024
Assigned To Examiner
Apr 19, 2024
Examiners Amendment -Written
Apr 19, 2024
Examiners Amendment E-Mailed
Apr 19, 2024
Notification Of Examiners Amendment E-Mailed
Apr 19, 2024
Examiner's Amendment Entered
Apr 19, 2024
Approved For Pub - Principal Register
May 8, 2024
Notification Of Notice Of Publication E-Mailed
May 28, 2024
Published For Opposition
May 28, 2024
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
